Mallinckrodt Announces UVADEX Approved In Australia For Use With The THERAKOS CELLEX Photopheresis System For Treatment Of Chronic Graft Versus Host Disease (cGvHD) And Skin Manifestations Of Cutaneous T-Cell Lymphoma (CTCL) In Adults
Benzinga Newsdesk